NO20022969L - Compositions and Methods for L-Nucleosides, L-Nucleotides and Analogs thereof - Google Patents
Compositions and Methods for L-Nucleosides, L-Nucleotides and Analogs thereofInfo
- Publication number
- NO20022969L NO20022969L NO20022969A NO20022969A NO20022969L NO 20022969 L NO20022969 L NO 20022969L NO 20022969 A NO20022969 A NO 20022969A NO 20022969 A NO20022969 A NO 20022969A NO 20022969 L NO20022969 L NO 20022969L
- Authority
- NO
- Norway
- Prior art keywords
- nucleosides
- nucleotides
- analogs
- compositions
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17209799P | 1999-12-23 | 1999-12-23 | |
US17344699P | 1999-12-29 | 1999-12-29 | |
US17511100P | 2000-01-06 | 2000-01-06 | |
US19075800P | 2000-03-20 | 2000-03-20 | |
US22694700P | 2000-08-22 | 2000-08-22 | |
US22687500P | 2000-08-22 | 2000-08-22 | |
US23382200P | 2000-09-19 | 2000-09-19 | |
US23354800P | 2000-09-19 | 2000-09-19 | |
US23382300P | 2000-09-19 | 2000-09-19 | |
US23382100P | 2000-09-19 | 2000-09-19 | |
US23546500P | 2000-09-26 | 2000-09-26 | |
PCT/US2000/034605 WO2001045509A1 (en) | 1999-12-23 | 2000-12-19 | Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022969L true NO20022969L (en) | 2002-06-20 |
NO20022969D0 NO20022969D0 (en) | 2002-06-20 |
Family
ID=27582702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022969A NO20022969D0 (en) | 1999-12-23 | 2002-06-20 | Compositions and Methods for L-Nucleosides, L-Nucleotides and Analogs thereof |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1244356A4 (en) |
JP (1) | JP2003523957A (en) |
KR (1) | KR20030032908A (en) |
CN (1) | CN1420723A (en) |
AU (1) | AU2442201A (en) |
BR (1) | BR0016162A (en) |
CA (1) | CA2384326A1 (en) |
CZ (1) | CZ20022112A3 (en) |
HK (1) | HK1049944A1 (en) |
HR (1) | HRP20020485A2 (en) |
HU (1) | HUP0300219A3 (en) |
IL (1) | IL148514A0 (en) |
MX (1) | MXPA02006251A (en) |
NO (1) | NO20022969D0 (en) |
NZ (1) | NZ517634A (en) |
PL (1) | PL364927A1 (en) |
SI (1) | SI20976A (en) |
SK (1) | SK8612002A3 (en) |
WO (1) | WO2001045509A1 (en) |
YU (1) | YU47802A (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
US6930093B2 (en) * | 2003-07-10 | 2005-08-16 | Valeant Research & Development | Use of ribofuranose derivatives against inflammatory bowel diseases |
WO2005023826A2 (en) | 2003-09-11 | 2005-03-17 | F.Hoffmann-La Roche Ag | Polymorphic nucleoside compounds |
US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
AU2007325551A1 (en) * | 2006-09-11 | 2008-06-05 | Arrowhead Center Inc. | Azole nucleosides and use as inhibitors of RNA and DNA varial polymerases |
CN102952104A (en) * | 2011-08-17 | 2013-03-06 | 黑龙江省松花江药业有限公司 | Furan compound |
EP3623364A1 (en) | 2014-02-13 | 2020-03-18 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
JP2017520545A (en) | 2014-07-02 | 2017-07-27 | リガンド・ファーマシューティカルズ・インコーポレイテッド | Prodrug compounds and their use |
CN104387431A (en) * | 2014-10-24 | 2015-03-04 | 江南大学 | Preparation method of high-specificity ribavirin artificial antigens |
EP3156050A1 (en) * | 2015-10-16 | 2017-04-19 | Universitat Autònoma De Barcelona | New combination therapies for treating neurological damage |
CN109528638B (en) * | 2018-12-20 | 2021-07-06 | 江西润泽药业有限公司 | Ribavirin derivative preparation and preparation method thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
AU5668886A (en) * | 1986-03-27 | 1987-10-20 | Harry Edward Gruber | A method of increasing adenosine excretion |
GB9019812D0 (en) * | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
US6387365B1 (en) * | 1995-05-19 | 2002-05-14 | Schering Corporation | Combination therapy for chronic hepatitis C infection |
US5981507A (en) * | 1995-12-14 | 1999-11-09 | Advanced Magnetics, Inc. | Polymeric carriers linked to nucleotide analogues via a phosphoramide bond |
CA2267279A1 (en) * | 1996-10-16 | 1998-04-23 | Devron Averett | Monocyclic l-nucleosides, analogs and uses thereof |
WO1999059621A1 (en) * | 1998-05-15 | 1999-11-25 | Schering Corporation | Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having g chronic hepatitis c infection |
US6277830B1 (en) * | 1998-10-16 | 2001-08-21 | Schering Corporation | 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon |
AU2026900A (en) * | 1998-11-20 | 2000-06-13 | Salk Institute For Biological Studies, The | Neuron stimulation by ribavirin, and analogs thereof |
-
2000
- 2000-12-19 CZ CZ20022112A patent/CZ20022112A3/en unknown
- 2000-12-19 PL PL00364927A patent/PL364927A1/en not_active Application Discontinuation
- 2000-12-19 IL IL14851400A patent/IL148514A0/en unknown
- 2000-12-19 BR BR0016162-4A patent/BR0016162A/en not_active IP Right Cessation
- 2000-12-19 SI SI200020047A patent/SI20976A/en not_active IP Right Cessation
- 2000-12-19 EP EP00988189A patent/EP1244356A4/en not_active Withdrawn
- 2000-12-19 SK SK861-2002A patent/SK8612002A3/en not_active Application Discontinuation
- 2000-12-19 YU YU47802A patent/YU47802A/en unknown
- 2000-12-19 AU AU24422/01A patent/AU2442201A/en not_active Abandoned
- 2000-12-19 JP JP2001546256A patent/JP2003523957A/en active Pending
- 2000-12-19 CA CA002384326A patent/CA2384326A1/en not_active Abandoned
- 2000-12-19 HU HU0300219A patent/HUP0300219A3/en unknown
- 2000-12-19 WO PCT/US2000/034605 patent/WO2001045509A1/en not_active Application Discontinuation
- 2000-12-19 MX MXPA02006251A patent/MXPA02006251A/en unknown
- 2000-12-19 CN CN00817416A patent/CN1420723A/en active Pending
- 2000-12-19 NZ NZ517634A patent/NZ517634A/en not_active Application Discontinuation
- 2000-12-19 KR KR1020027008069A patent/KR20030032908A/en not_active Application Discontinuation
-
2002
- 2002-06-03 HR HR20020485A patent/HRP20020485A2/en not_active Application Discontinuation
- 2002-06-20 NO NO20022969A patent/NO20022969D0/en not_active Application Discontinuation
-
2003
- 2003-03-28 HK HK03102255.3A patent/HK1049944A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1244356A4 (en) | 2003-03-19 |
JP2003523957A (en) | 2003-08-12 |
SI20976A (en) | 2003-02-28 |
HK1049944A1 (en) | 2003-06-06 |
CA2384326A1 (en) | 2001-06-28 |
BR0016162A (en) | 2002-08-13 |
HUP0300219A3 (en) | 2005-07-28 |
NZ517634A (en) | 2004-06-25 |
YU47802A (en) | 2006-03-03 |
AU2442201A (en) | 2001-07-03 |
CN1420723A (en) | 2003-05-28 |
EP1244356A1 (en) | 2002-10-02 |
NO20022969D0 (en) | 2002-06-20 |
SK8612002A3 (en) | 2003-03-04 |
KR20030032908A (en) | 2003-04-26 |
MXPA02006251A (en) | 2003-01-28 |
PL364927A1 (en) | 2004-12-27 |
IL148514A0 (en) | 2002-09-12 |
WO2001045509A1 (en) | 2001-06-28 |
HRP20020485A2 (en) | 2005-10-31 |
CZ20022112A3 (en) | 2003-05-14 |
HUP0300219A2 (en) | 2003-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012158D0 (en) | Substituted 2-phenylbenzimidazoles, process for preparation and use thereof | |
DK1180518T3 (en) | 5-pyridyl-1,3-azole compounds, process for their preparation and use thereof | |
DK1307744T3 (en) | analyzer | |
NO20004758L (en) | vaccine Composition | |
LU92057I2 (en) | Vandetanib (CAPRELSA) | |
NO20000011D0 (en) | Antifoam compositions and methods | |
EE04027B1 (en) | Buffer | |
DE69930157D1 (en) | TRIPHASIC, ORAL CONTRAZEPTIVUM | |
DK1339292T3 (en) | Composition and method | |
DK1073672T3 (en) | Antipicornaviral compounds, their preparation and use | |
DK1261697T3 (en) | Cold-active beta-galactosidase, process for its preparation and its use | |
NO20030800D0 (en) | Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, process and preparation containing the same | |
NO20022969D0 (en) | Compositions and Methods for L-Nucleosides, L-Nucleotides and Analogs thereof | |
DE60213940D1 (en) | Sample introduction system | |
NO20006479D0 (en) | Tienopyridine compounds, their preparation and use | |
ID30126A (en) | METHODS FOR PRODUCING SIKLO- (Asp-DPhe-NMeVal-Arg-Gly) | |
DE29903520U1 (en) | Jaw | |
IT1310896B1 (en) | ARTICULATOR FOR DENTAL TECHNIQUE. | |
ZA200202778B (en) | Compositions and methods for L-nucleosides, L-nucleotides, and their analogs. | |
ES1045770Y (en) | MANDIBULAR CORRECTOR APPARATUS. | |
ES1042540Y (en) | PERFECTED PSYCHROMETER. | |
FI990172A0 (en) | Marvi method | |
DK1127052T3 (en) | Substituted 2-phenylbenzimidazoles, preparation and use thereof | |
IT245508Y1 (en) | INTERCONNECTION DEVICE, PARTICULARLY FOR FURNITURE COMPONENTS | |
IT249628Y1 (en) | LINE-HOLDER FOR ORDITOI |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |